Skip to main
MRSN
MRSN logo

Mersana Therapeutics (MRSN) Market Capitalization Overview

Market Cap: $51.06M as of Oct 28, 2025

$51.06M
Past Month+$13.28M (35.14%)
As of Oct 28, 2025, Mersana Therapeutics (MRSN) has a market capitalization of $51.06M. Over the past 30 days, its market cap has increased by 13.11%, while in the last 12 months, it has decreased by -69.13%.

Market capitalization represents the total value of Mersana Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Mersana Therapeutics (MRSN) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Mersana Therapeutics (MRSN) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Mersana Therapeutics (MRSN) Market Cap History

DateMarket CapChange
Oct 1, 2025$39.63M+13.11%
Sep 2, 2025$35.04M+6.48%
Aug 1, 2025$32.91M-5.48%
Jul 1, 2025$34.82M-25.30%
Jun 2, 2025$46.60M-6.52%
May 1, 2025$49.86M+19.65%
Apr 1, 2025$41.67M-24.95%
Mar 3, 2025$55.52M-15.10%
Feb 3, 2025$65.39M-59.61%
Jan 2, 2025$161.91M-42.71%

Mersana Therapeutics (MRSN) End of Year Market Cap History

DateMarket CapChange
2025$51.06M-69.13%
2024$165.38M-40.87%
2023$279.68M-51.59%
2022$577.70M+26.00%
2021$458.48M-99.00%
2020$45.80B

FAQs About Mersana Therapeutics (MRSN) Market Cap

As of Oct 28, 2025, the market capitalization of Mersana Therapeutics (MRSN) is $51.06M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Mersana Therapeutics’s market capitalization has increased by 35.14%, changing from $37.78M to $51.06M as of Oct 28, 2025.

In the last 3 months, Mersana Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Mersana Therapeutics’s market capitalization decreased from $279.68M in January to $165.38M in December, reflecting a -40.87% change.

In the past five years, Mersana Therapeutics (MRSN) has had a compound annual growth rate (CAGR) of -67.53% in market capitalization. This means its market cap has shrunk at an average rate of -67.53% per year.

Mersana Therapeutics (MRSN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.